Tepotinib in patients with MET exon 14 skipping non-small cell lung cancer
Cancer Treatment Reviews · 2025-09 · 139 · 102990
DOI: 10.1016/j.ctrv.2025.102990 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Treatment Reviews, 2025-09. Verfasst von Paul K Paik und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Thoracic Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA; Weill Cornell Medical College, New York…. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Proto-Oncogene Proteins c-met, Pyrimidines. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research and Development, Merck KGaA, EMD Serono.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Thoracic Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA; Weill Cornell Medical College, New York, NY, USA. Electronic address: paikp@mskcc.org.
- Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
- Divisions of Hematology-Oncology and Bone Marrow Transplantation, University of California, San Diego, CA, USA.
- EMD Serono, Inc., Boston, MA, USA, an affiliate of Merck KGaA.
- EMD Inc., Mississauga, Ontario, Canada, an affiliate of Merck KGaA.
- Department of Thoracic/Head and Neck Medical Oncology, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Förderung
- Research and Development
- Merck KGaA
- EMD Serono
Zitieren
APA
Paik, P. K., Iams, W. T., Husain, H., O'Hara, R. M., Adewusi, E., & Le, X. (2025). Tepotinib in patients with MET exon 14 skipping non-small cell lung cancer. Cancer Treatment Reviews, 139, 102990. https://doi.org/10.1016/j.ctrv.2025.102990
Vancouver
Paik PK, Iams WT, Husain H, O'Hara RM, Adewusi E, Le X. Tepotinib in patients with MET exon 14 skipping non-small cell lung cancer. Cancer Treatment Reviews. 2025;139:102990. doi:10.1016/j.ctrv.2025.102990
BibTeX
@article{Paik2025,
author = {Paik, Paul K and Iams, Wade T and Husain, Hatim and O'Hara, Richard M and Adewusi, Emmanuel and Le, Xiuning},
title = {Tepotinib in patients with MET exon 14 skipping non-small cell lung cancer},
journal = {Cancer Treatment Reviews},
year = {2025},
volume = {139},
pages = {102990},
doi = {10.1016/j.ctrv.2025.102990}
}
EUVIMED